Swiss National Bank Makes New $10.43 Million Investment in agilon health, inc. (NYSE:AGL)

Swiss National Bank bought a new position in agilon health, inc. (NYSE:AGLGet Rating) in the second quarter, HoldingsChannel.com reports. The institutional investor bought 477,800 shares of the company’s stock, valued at approximately $10,430,000.

Other hedge funds have also added to or reduced their stakes in the company. Level Financial Advisors Inc. bought a new stake in agilon health in the second quarter worth approximately $25,000. First Horizon Advisors Inc. increased its holdings in agilon health by 772.7% in the first quarter. First Horizon Advisors Inc. now owns 1,213 shares of the company’s stock worth $31,000 after purchasing an additional 1,074 shares in the last quarter. Lazard Asset Management LLC bought a new stake in agilon health in the first quarter worth approximately $69,000. SG Americas Securities LLC bought a new stake in agilon health in the second quarter worth approximately $173,000. Finally, Bridgefront Capital LLC bought a new stake in agilon health in the first quarter worth approximately $212,000.

agilon health Stock Up 3.3 %

Shares of NYSE:AGL opened at $17.17 on Monday. The stock has a market cap of $7.07 billion, a price-to-earnings ratio of -66.04 and a beta of 0.93. The company has a quick ratio of 2.48, a current ratio of 2.48 and a debt-to-equity ratio of 0.04. agilon health, inc. has a 12-month low of $14.36 and a 12-month high of $28.36. The business’s 50 day moving average is $21.24 and its 200 day moving average is $21.66.

Insider Activity at agilon health

In related news, insider Benjamin Shaker sold 29,548 shares of agilon health stock in a transaction that occurred on Thursday, October 20th. The stock was sold at an average price of $20.37, for a total transaction of $601,892.76. Following the transaction, the insider now owns 25,625 shares of the company’s stock, valued at $521,981.25. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other agilon health news, insider Benjamin Kornitzer sold 8,094 shares of the business’s stock in a transaction on Friday, September 9th. The stock was sold at an average price of $23.08, for a total value of $186,809.52. Following the transaction, the insider now owns 10,853 shares of the company’s stock, valued at $250,487.24. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Benjamin Shaker sold 29,548 shares of the business’s stock in a transaction on Thursday, October 20th. The stock was sold at an average price of $20.37, for a total value of $601,892.76. Following the completion of the transaction, the insider now directly owns 25,625 shares in the company, valued at approximately $521,981.25. The disclosure for this sale can be found here. Insiders have sold a total of 72,716 shares of company stock valued at $1,578,866 over the last 90 days. Insiders own 3.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on AGL shares. The Goldman Sachs Group lowered their target price on agilon health from $38.00 to $34.00 and set a “buy” rating for the company in a report on Tuesday, November 15th. SVB Leerink reduced their price objective on agilon health from $33.00 to $30.00 and set an “outperform” rating for the company in a research note on Friday, November 4th. TheStreet cut agilon health from a “c-” rating to a “d+” rating in a research note on Thursday, August 18th. Truist Financial reduced their price objective on agilon health from $33.00 to $29.00 and set a “buy” rating for the company in a research note on Wednesday, September 7th. Finally, Wells Fargo & Company reduced their price objective on agilon health from $28.00 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, November 15th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.14.

About agilon health

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

Read More

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLGet Rating).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.